BioXcel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.

About BTAI

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. 

CEO
Vimal D. Mehta
CEOVimal D. Mehta
Employees
29
Employees29
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2017
Founded2017
Employees
29
Employees29

BTAI Key Statistics

Market cap
26.39M
Market cap26.39M
Price-Earnings ratio
-0.14
Price-Earnings ratio-0.14
Dividend yield
Dividend yield
Average volume
435.06K
Average volume435.06K
High today
$0.886
High today$0.886
Low today
$0.84
Low today$0.84
Open price
$0.87
Open price$0.87
Volume
319.17K
Volume319.17K
52 Week high
$8.08
52 Week high$8.08
52 Week low
$0.7365
52 Week low$0.7365

Stock Snapshot

As of today, BioXcel Therapeutics(BTAI) shares are valued at $0.84. The company's market cap stands at 26.39M, with a P/E ratio of -0.14.

On 2026-08-06, BioXcel Therapeutics(BTAI) stock traded between a low of $0.84 and a high of $0.89. Shares are currently priced at $0.84, which is +0.1% above the low and -5.1% below the high.

The BioXcel Therapeutics(BTAI)'s current trading volume is 319.17K, compared to an average daily volume of 435.06K.

During the past year, BioXcel Therapeutics(BTAI) stock moved between $0.74 at its lowest and $8.08 at its peak.

During the past year, BioXcel Therapeutics(BTAI) stock moved between $0.74 at its lowest and $8.08 at its peak.

BTAI News

TipRanks 3d
BioXcel Therapeutics Amends Credit Agreement, Extends Debt Deadline

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

People also own

Based on the portfolios of people who own BTAI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.